Edwards Lifesciences Stock Forecast

Stock Price Forecast

According to 29 analysts polled by S&P Global, Edwards Lifesciences stock has a consensus rating of "Buy" and an average price target of $96.92. The average 1-year stock price forecast is 13.36% higher than the current stock price, while the lowest is $84 (-1.75%) and the highest is $110 (+28.65%).

Price Target: $96.92 (+13.36%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$84	$96.92	$100	$110
Change	-1.75%	+13.36%	+16.96%	+28.65%

Analyst Ratings

The average analyst rating for Edwards Lifesciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	16	16	16	17	17	17
Buy	5	5	5	5	4	4
Hold	12	12	10	8	8	8
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	33	33	31	30	29	29

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Josh Jennings TD Cowen	TD Cowen	Buy Reiterates $104	Buy	Reiterates	$104	+21.64%	Jun 2, 2026
Joanne Wuensch Citi	Citi	Buy Reiterates $101	Buy	Reiterates	$101	+18.13%	May 28, 2026
Matthew Taylor Jefferies	Jefferies	Buy Maintains $102	Buy	Maintains	$102	+19.30%	May 27, 2026
David Toung Argus Research	Argus Research	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 22, 2026
Vijay Kumar Evercore ISI	Evercore ISI	Buy Maintains $93	Buy	Maintains	$93	+8.77%	May 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.75B

from 6.07B

11.19%

from 6.07B

Revenue Next Year

7.41B

from 6.75B

9.82%

from 6.75B

EPS This Year

3.01

from 2.56

17.48%

from 2.56

EPS Next Year

3.37

from 3.01

11.98%

from 3.01

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	5.23B	4.46B	5.01B	5.44B	6.07B	6.75B
Revenue Growth	19.29%	-14.69%	12.23%	8.57%	11.55%	11.19%
Gross Profit	3.98B	3.74B	4.03B	4.32B	4.73B	5.29B
Gross Margin	76.13%	83.82%	80.47%	79.46%	78.01%	78.41%
Operating Income	1.59B	1.54B	1.49B	1.48B	1.64B	1.96B
Net Income	1.50B	1.52B	1.40B	4.17B	1.07B	1.62B
EPS	-	-	-	-	2.56	3.01
EPS Growth	-	-	-	-	5.35%	17.48%
Forward PE	52.98	30.35	28.41	31.19	30.93	28.43
Free Cash Flow	1.01B	776.73M	566.93M	1.34B	1.17B	1.36B
No. Analysts	-	-	-	-	-	28

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	6.8B
Avg	6.7B
Low	6.6B

Revenue Growth

Revenue Growth	2026	2027	2028
High	12.3%
Avg	11.2%
Low	9.1%

EPS Forecast

EPS	2026	2027	2028
High	3.05
Avg	3.01
Low	2.97

EPS Growth

EPS Growth	2026	2027	2028
High	19.1%
Avg	17.5%
Low	16.0%